Research Article
Dose-Painted Intensity Modulated Radiation Therapy Improves Local Control for Locally Advanced Pancreas Cancer
Table 1
Patient demographics and treatment regimens.
| Characteristic | (%) |
| Gender | | Male | 14 (54) | Female | 12 (46) | Age (years) | | Median (range) | 66 (40–87) | T stage | | T2 | 1 (4) | T3 | 12 (46) | T4 | 13 (50) | N stage | | N0 | 10 (38) | N1 | 10 (38) | Unknown | 6 (23) | Induction chemotherapy | | Gemcitabine | 22 (85) | Gemcitabine-paclitaxel-capecitabine (GTX) | 1 (4) | 5-Fluorouracil-leucovorin-irinotecan-oxaliplatin (FOLFIRINOX) | 2 (8) | No induction chemotherapy | 1 (4) | Concurrent chemotherapy | | Gemcitabine | 7 (35) | 5-FU | 12 (60) | Both | 1 (5) |
|
|